Most people recognize Alzheimer’s disease from its devastating symptoms such as memory loss, while new drugs target pathological aspects of disease manifestations, such as plaques of amyloid proteins.

Turning genes on and off is like flipping a light switch, controlling whether genes in a cell are active. When a gene is ...

Stanford researchers and their collaborators have revealed a new device that could change the way scientists conduct ...

In a development that could help protect one of the world's most beloved agricultural commodities, a research team at Penn ...

Turning genes on and off is like flipping a light switch, controlling whether genes in a cell are active. When a gene is ...

In preclinical models, Mass General Brigham researchers’ CRISPR-Cas9 gene therapy precisely repaired the genetic error that causes a rare vascular disease The ...

Exclusive license with Yeda Research and Development Company, Weizmann Institute’s commercial arm, broadens Vyriad’s delivery portfolio with a novel viral targeting approach designed to preserve ...

In recent years, tech stocks have become a focal point for investors seeking growth, with companies at the forefront of innovation often experiencing significant market volatility. This environment ...

Celletto™ is a disruptive nanomechanical gene delivery technology that addresses long-standing limitations of both viral vectors and conventional non-viral methods. By creating a controlled, transient ...

Anthropic CEO Dario Amodei has reiterated that artificial intelligence could soon displace large numbers of entry-level workers. Speaking to Amol Rajan on BBC’s Radical, Amodei said ...